(Q37095373)

18 August 2017

1 reference

title

Advanced formulation design: improving drug therapies for the management of severe and chronic pain (English)

1 reference

18 August 2017

0 references

0 references

Dave A Miller

1

1 reference

18 August 2017

James C Dinunzio

series ordinal

2

1 reference

18 August 2017

Robert O Williams

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

Drug Development and Industrial Pharmacy

18 August 2017

1 reference

18 August 2017

34

1 reference

18 August 2017

2

1 reference

18 August 2017

117-133

1 reference

Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Overview of oral modified-release opioid products for the management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Oxycontin: the concept of a "ghost pill" and the postmortem tissue distribution of oxycodone in 36 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Case studies in swelling polymeric gastric retentive tablets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Retrospective analysis of Kadian (morphine sulfate sustained-release capsules) in patients with chronic, nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

In vitro and in vivo percutaneous absorption of topical dosage forms: case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Pulmonary delivery of opioids as pain therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

The role of opioids in cancer pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Primary care and pain medicine. A community solution to the public health problem of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Inhaled nebulised fentanyl for postoperative analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Ketamine in chronic pain management: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Pharmacokinetics of inhaled liposome-encapsulated fentanyl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

21 January 2018

Oxymorphone: a review

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Opioid formulations: tailoring to the needs in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Gabapentin: pharmacology and its use in pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Inhaled fentanyl as a method of analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040701542200

10.1080/03639040701542200

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference